Emeryville, CA, United States of America

Paul Glidden

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ucb Biosciences, Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paul Glidden: Innovator in Aqueous Solutions

Introduction

Paul Glidden is a notable inventor based in Emeryville, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of aqueous solutions containing purines and pyrimidines. His work has implications for treating mitochondrial depletion syndromes, showcasing the intersection of chemistry and medicine.

Latest Patents

Paul Glidden holds 1 patent for his invention titled "Aqueous solutions containing purines and pyrimidines and uses thereof." This patent describes compositions that include a first heteroaryl compound and a second heteroaryl compound dissolved in an aqueous liquid. The methods outlined in the patent involve orally administering this aqueous liquid to patients diagnosed with mitochondrial depletion syndrome. Additionally, the patent includes kits that comprise the necessary compounds and instructions for their preparation and administration.

Career Highlights

Throughout his career, Paul has been associated with Ucb Biosciences, Inc., where he has focused on innovative solutions in biochemistry. His work has contributed to advancements in therapeutic methods, particularly in the treatment of complex medical conditions.

Collaborations

Paul collaborates with Eric Scharin, working together to further their research and development efforts in the field of biochemistry. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Paul Glidden's contributions to the field of aqueous solutions and their applications in medicine highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…